Speaker illustration

Doctor Mai Kimura

Keio University Hospital, Tokyo (Japan)

De-escalation/discontinuation of oxygen-therapy and medication is feasible and safe in chronic thromboembolic pulmonary hypertension patients treated with balloon pulmonary angioplasty

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Pulmonary Hypertension

Session: Advances in Chronic Thromboembolic Pulmonary Hypertension

Thumbnail

The impact of left ventricular dysfunction on in-hospital complications and 1-year prognosis in patients undergoing percutaneous coronary intervention in Japan: a report from KiCS-PCI-Registry.

Event: ESC CONGRESS 2017

Topic: PCI: procedural complications

Session: PCI - Procedure complications

Thumbnail

Mid-term effect of balloon pulmonary angioplasty on hemodynamics and subclinical myocardial damage in chronic thromboembolic pulmonary hypertension patients

Event: ESC CONGRESS 2016

Topic: Pulmonary circulation, other

Session: Pulmonary circulation imaging

Thumbnail

De-escalation/discontinuation of oxygen-therapy and medication is feasible and safe in chronic thromboembolic pulmonary hypertension patients treated with balloon pulmonary angioplasty

Event: ESC Asia with APSC & AFC 2020

Topic: Pulmonary Hypertension

Session: Abstract Programme

Thumbnail

ESC 365 is supported by

logo Novo Nordisk